The Evolving Landscape of Biomarkers in Celiac Disease: Leading the Way to Clinical Development

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2021 Apr 26

PMID 33897715

Citations 5

Authors

Glennda Smithson

Jenifer Siegelman

Toshihiko Oki

Joseph R Maxwell

Daniel A Leffler

Affiliations

Soon will be listed here.

Abstract

Celiac disease is a common immune-mediated disease characterized by abnormal T-cell responses to gluten. For many patients, symptoms and intestinal damage can be controlled by a gluten-free diet, but, for some, this approach is not enough, and celiac disease progresses, with serious medical consequences. Multiple therapies are now under development, increasing the need for biomarkers that allow identification of specific patient populations and monitoring of therapeutic activity and durability. The advantage of identifying biomarkers in celiac disease is that the underlying pathways driving disease are well characterized and the histological, cellular, and serological changes with gluten response have been defined in gluten challenge studies. However, there is room for improvement. Biomarkers that measure histological changes require duodenal biopsies and are invasive. Less invasive peripheral blood cell and cytokine biomarkers are transient and dependent upon gluten challenge. Here, we discuss established biomarkers and new approaches for biomarkers that may overcome current limitations.

Citing Articles

Evolution in coeliac disease diagnosis and management.

Tye-Din J JGH Open. 2024; 8(7):e13107.

PMID: 38957478 PMC: 11217771. DOI: 10.1002/jgh3.13107.

An Interpretable Classification Model Using Gluten-Specific TCR Sequences Shows Diagnostic Potential in Coeliac Disease.

Fowler A, Fitzpatrick M, Shanmugarasa A, Ibrahim A, Kockelbergh H, Yang H Biomolecules. 2023; 13(12).

PMID: 38136579 PMC: 10742135. DOI: 10.3390/biom13121707.

Nutritional Health Perspective of Natto: A Critical Review.

Afzaal M, Saeed F, Islam F, Ateeq H, Asghar A, Shah Y Biochem Res Int. 2022; 2022:5863887.

PMID: 36312453 PMC: 9616652. DOI: 10.1155/2022/5863887.

Review article: Follow-up of coeliac disease.

Tye-Din J Aliment Pharmacol Ther. 2022; 56 Suppl 1:S49-S63.

PMID: 35815829 PMC: 9542881. DOI: 10.1111/apt.16847.

Frequency of serological markers of rheumatoid arthritis in adult patients with active celiac disease.

Ghozzi M, Melayah S, Adaily N, Ghedira I J Clin Lab Anal. 2022; 36(3):e24249.

PMID: 35060192 PMC: 8906036. DOI: 10.1002/jcla.24249.

References

Rubio-Tapia A, Hill I, Kelly C, Calderwood A, Murray J . ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013; 108(5):656-76. PMC: 3706994. DOI: 10.1038/ajg.2013.79. View

Singh P, Arora A, Strand T, Leffler D, Catassi C, Green P . Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2018; 16(6):823-836.e2. DOI: 10.1016/j.cgh.2017.06.037. View

Anderson R, Degano P, Godkin A, Jewell D, Hill A . In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med. 2000; 6(3):337-42. DOI: 10.1038/73200. View

Lahdeaho M, Scheinin M, Vuotikka P, Taavela J, Popp A, Laukkarinen J . Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study. Lancet Gastroenterol Hepatol. 2019; 4(12):948-959. DOI: 10.1016/S2468-1253(19)30264-X. View

Leffler D, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly C . Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007; 5(4):445-50. DOI: 10.1016/j.cgh.2006.12.006. View

Raki M, Fallang L, Brottveit M, Bergseng E, Quarsten H, Lundin K . Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patients. Proc Natl Acad Sci U S A. 2007; 104(8):2831-6. PMC: 1800789. DOI: 10.1073/pnas.0608610104. View

Petersen J, van Bergen J, Loh K, Kooy-Winkelaar Y, Beringer D, Thompson A . Determinants of gliadin-specific T cell selection in celiac disease. J Immunol. 2015; 194(12):6112-22. DOI: 10.4049/jimmunol.1500161. View

Husby S, Murray J, Katzka D . AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review. Gastroenterology. 2018; 156(4):885-889. PMC: 6409202. DOI: 10.1053/j.gastro.2018.12.010. View

Diez-Sampedro A, Olenick M, Maltseva T, Flowers M . A Gluten-Free Diet, Not an Appropriate Choice without a Medical Diagnosis. J Nutr Metab. 2019; 2019:2438934. PMC: 6636598. DOI: 10.1155/2019/2438934. View

10.

Christophersen A, Raki M, Bergseng E, Lundin K, Jahnsen J, Sollid L . Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. United European Gastroenterol J. 2014; 2(4):268-78. PMC: 4114117. DOI: 10.1177/2050640614540154. View

11.

Choung R, Mills J, Snyder M, Murray J, Gandhi M . Celiac disease risk stratification based on HLA-DQ heterodimer (HLA-DQA1 ~ DQB1) typing in a large cohort of adults with suspected celiac disease. Hum Immunol. 2020; 81(2-3):59-64. DOI: 10.1016/j.humimm.2020.01.006. View

12.

Ludvigsson J, Ciacci C, Green P, Kaukinen K, Korponay-Szabo I, Kurppa K . Outcome measures in coeliac disease trials: the Tampere recommendations. Gut. 2018; 67(8):1410-1424. PMC: 6204961. DOI: 10.1136/gutjnl-2017-314853. View

13.

Cellier C, Bouma G, van Gils T, Khater S, Malamut G, Crespo L . Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study. Lancet Gastroenterol Hepatol. 2019; 4(12):960-970. DOI: 10.1016/S2468-1253(19)30265-1. View

14.

Karinen H, Karkkainen P, Pihlajamaki J, Janatuinen E, Heikkinen M, Julkunen R . Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease. Scand J Gastroenterol. 2006; 41(2):191-9. DOI: 10.1080/00365520500206277. View

15.

Risnes L, Christophersen A, Dahal-Koirala S, Neumann R, Sandve G, Sarna V . Disease-driving CD4+ T cell clonotypes persist for decades in celiac disease. J Clin Invest. 2018; 128(6):2642-2650. PMC: 5983310. DOI: 10.1172/JCI98819. View

16.

Caio G, Volta U, Sapone A, Leffler D, De Giorgio R, Catassi C . Celiac disease: a comprehensive current review. BMC Med. 2019; 17(1):142. PMC: 6647104. DOI: 10.1186/s12916-019-1380-z. View

17.

Ting Y, Dahal-Koirala S, Kim H, Qiao S, Neumann R, Lundin K . A molecular basis for the T cell response in HLA-DQ2.2 mediated celiac disease. Proc Natl Acad Sci U S A. 2020; 117(6):3063-3073. PMC: 7022145. DOI: 10.1073/pnas.1914308117. View

18.

Tye-Din J, Skodje G, Sarna V, Dzuris J, Russell A, Goel G . Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity. United European Gastroenterol J. 2020; 8(1):108-118. PMC: 7006000. DOI: 10.1177/2050640619874173. View

19.

Brown N, Guandalini S, Semrad C, Kupfer S . A Clinician's Guide to Celiac Disease HLA Genetics. Am J Gastroenterol. 2019; 114(10):1587-1592. DOI: 10.14309/ajg.0000000000000310. View

20.

Yao Y, Zia A, Neumann R, Pavlovic M, Balaban G, Lundin K . T cell receptor repertoire as a potential diagnostic marker for celiac disease. Clin Immunol. 2020; 222:108621. DOI: 10.1016/j.clim.2020.108621. View